GSK’s Arexvy vaccine approved to protect older adults from respiratory syncytial virus (RSV) disease in Malaysia

KUALA LUMPUR, Oct 3 — GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Mala…

KUALA LUMPUR, Oct 3 — GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy has been approved in Mala…
Read More

About Author